Visceral leishmaniasis relapse in Southern Sudan (1999-2007): a retrospective study of risk factors and trends.

Visceral leishmaniasis relapse in Southern Sudan (1999-2007): a retrospective study of risk factors and trends.

BACKGROUND: Risk factors associated with L. donovani visceral leishmaniasis (VL; kala azar) relapse are poorly characterized. METHODS: We investigated patient characteristics and drug regimens associated with VL relapse using data from Médecins Sans Frontières - Holland (MSF) treatment centres in So...

Full description

Bibliographic Details
Main Authors:	Stanislaw Gorski, Simon M Collin, Koert Ritmeijer, Kees Keus, Francis Gatluak, Marius Mueller, Robert N Davidson
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2010-01-01
Series:	PLoS Neglected Tropical Diseases
Online Access:	http://europepmc.org/articles/PMC2882338?pdf=render

Similar Items

A clinical severity scoring system for visceral leishmaniasis in immunocompetent patients in South Sudan.
by: Suzette S Kämink, et al.
Published: (2017-10-01)

The increasing incidence of visceral leishmaniasis relapse in South Sudan: A retrospective analysis of field patient data from 2001-2018.
by: Gabriel Naylor-Leyland, et al.
Published: (2022-08-01)

Correction: The increasing incidence of visceral leishmaniasis relapse in South Sudan: A retrospective analysis of field patient data from 2001-2018.
by: Gabriel Naylor-Leyland, et al.
Published: (2024-02-01)

Outcomes of visceral leishmaniasis in pregnancy: A retrospective cohort study from South Sudan.
by: Judith E Pekelharing, et al.
Published: (2020-01-01)

A Comparison of the Effectiveness of Sodium Stibogluconate Monotherapy to Sodium Stibogluconate and Paromomycin Combination for the Treatment of Severe Post Kala Azar Dermal Leishmaniasis in South Sudan - A Retrospective Cohort Study.
by: Charles Abongomera, et al.
Published: (2016-01-01)

Determinants of Visceral Leishmaniasis: A Case-Control Study in Gedaref State, Sudan.
by: Fabienne Nackers, et al.
Published: (2015-11-01)

Burden of visceral leishmaniasis in villages of eastern Gedaref State, Sudan: an exhaustive cross-sectional survey.
by: Yolanda Kathrin Mueller, et al.
Published: (2012-01-01)

Visceral Leishmaniasis and HIV coinfection in East Africa.
by: Ermias Diro, et al.
Published: (2014-06-01)

Anticipating visceral leishmaniasis epidemics due to the conflict in Northern Ethiopia.
by: Carl Boodman, et al.
Published: (2023-03-01)

Anticipating visceral leishmaniasis epidemics due to the conflict in Northern Ethiopia
by: Carl Boodman, et al.
Published: (2023-03-01)

Visceral leishmaniasis as an AIDS defining condition: towards consistency across WHO guidelines.
by: Johan van Griensven, et al.
Published: (2014-07-01)

Effectiveness and safety of short course liposomal amphotericin B (AmBisome) as first line treatment for visceral leishmaniasis in Bangladesh.
by: Emiliano Lucero, et al.
Published: (2015-04-01)

Leishmania Antigenuria to Predict Initial Treatment Failure and Relapse in Visceral Leishmaniasis/HIV Coinfected Patients: An Exploratory Study Nested Within a Clinical Trial in Ethiopia
by: Johan van Griensven, et al.
Published: (2018-03-01)

Relationship of serum antileishmanial antibody with development of visceral leishmaniasis, post-kala-azar dermal leishmaniasis and visceral leishmaniasis relapse
by: Mondal, D, et al.
Published: (2019)

Relationship of Serum Antileishmanial Antibody With Development of Visceral Leishmaniasis, Post-kala-azar Dermal Leishmaniasis and Visceral Leishmaniasis Relapse
by: Dinesh Mondal, et al.
Published: (2019-10-01)

Visceral Leishmaniasis in pregnancy and vertical transmission: A systematic literature review on the therapeutic orphans.
by: Prabin Dahal, et al.
Published: (2021-08-01)

Risk factors of inpatients mortality of visceral leishmaniasis, Khartoum State, Sudan
by: Omaima Abdel Majeed Mohamed Salih, et al.
Published: (2020-01-01)

Correction: The increasing incidence of visceral leishmaniasis relapse in South Sudan: A retrospective analysis of field patient data from 2001–2018
Published: (2024-02-01)

Use of Pentamidine As Secondary Prophylaxis to Prevent Visceral Leishmaniasis Relapse in HIV Infected Patients, the First Twelve Months of a Prospective Cohort Study.
by: Ermias Diro, et al.
Published: (2015-01-01)

Sandflies (Diptera: Psychodidae) in a focus of visceral leishmaniasis in White Nile, Sudan
by: Sally Osman Widaa, et al.
Published: (2012-06-01)

Control of visceral leishmaniasis in East Africa: fragile progress, new threats
by: Margriet den Boer, et al.
Published: (2021-08-01)

Fractional-order modeling of visceral leishmaniasis disease transmission dynamics : strategies in eastern Sudan
by: Ghada A. Ahmed
Published: (2023-11-01)

Predictors of relapse of visceral leishmaniasis in inner São Paulo State, Brazil
by: José Cláudio Simão, et al.
Published: (2020-06-01)

Severe post-kala-azar dermal leishmaniasis successfully treated with miltefosine in an Ethiopian HIV patient
by: Charles Abongomera, et al.
Published: (2019-04-01)

Paromomycin for the treatment of visceral leishmaniasis in Sudan: a randomized, open-label, dose-finding study.
by: Ahmed M Musa, et al.
Published: (2010-10-01)

Mucosal relapse of visceral leishmaniasis in a child treated with anti-TNFα
by: E. Jeziorski, et al.
Published: (2015-04-01)

Predictors of visceral leishmaniasis relapse in HIV-infected patients: a systematic review.
by: Gláucia F Cota, et al.
Published: (2011-06-01)

Visceral leishmaniasis outbreak in South Sudan 2009-2012: epidemiological assessment and impact of a multisectoral response.
by: Abdinasir Abubakar, et al.
Published: (2014-03-01)

The initial effectiveness of liposomal amphotericin B (AmBisome) and miltefosine combination for treatment of visceral leishmaniasis in HIV co-infected patients in Ethiopia: A retrospective cohort study.
by: Charles Abongomera, et al.
Published: (2018-05-01)

Mucosal Relapse of Visceral Leishmaniasis in a Child with SARS-CoV-2 Infection
by: Claudia Colomba, et al.
Published: (2023-09-01)

Is splenectomy an option for multiple relapses in a child with visceral leishmaniasis? A case report
by: Marcos Adriano Garcia Campos, et al.
Published: (2021-03-01)

Amphotericin B deoxycholate for relapse visceral leishmaniasis in Bangladesh: a cross-sectional study
by: Md Golam Hasnain, et al.
Published: (2018-12-01)

Two cases of relapsed HIV-associated visceral leishmaniasis successfully treated with combination therapy
by: Antonio Mastroianni, et al.
Published: (2018-12-01)

Visceral leishmaniasis relapse in HIV patients--a role for myeloid-derived suppressor cells?
by: Rafael Van den Bergh, et al.
Published: (2014-09-01)

Patterns and drivers of Human Visceral Leishmaniasis in Pernambuco (Brazil) from 2007 to 2018.
by: Carolina Angélica Libório Machado, et al.
Published: (2023-02-01)

EPIDEMIOLOGICAL ASPECTS OF HUMAN VISCERAL LEISHMANIASIS IN THE STATE OF PIAUÍ, BRAZIL (2007-2017)
by: Henrique Rafael Pontes Ferreira, et al.
Published: (2021-09-01)

Epidemiological aspects of visceral leishmaniasis (kala-azar) in Ceará in the period 2007 to 2011
by: Ítalo José Mesquita Cavalcante, et al.
Published: (2014-12-01)

Visceral Leishmaniasis in pregnancy and vertical transmission: A systematic literature review on the therapeutic orphans
by: Dahal, P, et al.
Published: (2021)

Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia.
by: Charles Abongomera, et al.
Published: (2017-01-01)

Assessment of Variation in Clinical Presentation of Visceral Leishmaniasis Among Patients Attending the Tropical Diseases Teaching Hospital in Sudan
by: Hammam Abdalrhman Altom Mohammed Ahmed, et al.
Published: (2022-09-01)